Plus Therapeutics | CYTX - Selling And Administration Expenses

Stock Price
0.23
Daily Change
-0.01 -5.31%
Monthly
-23.23%
Yearly
-80.17%
Q1 Forecast
0.22

Plus Therapeutics reported $1.92M in Selling and Administration Expenses for its fiscal quarter ending in June of 2023.





Selling And Administration Expenses Change Date
Baxter International USD 761M 53M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Infinity Pharmaceuticals USD 3.75M 2.19M Jun/2023
Northwest Biotherapeutics USD 7.03M 534K Sep/2023
Sanofi EUR 2.75B 455M Dec/2025
Starpharma Holdings AUD 4.42M 2.86M Dec/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025